Serotonin receptor modulation in irritable bowel syndrome: One step forwards and one step backwards

Gut

Volumn 48, Issue 5, 2001, Pages 596-597

  Whorwell, P J ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; PLACEBO; SEROTONIN RECEPTOR;

ADULT; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; CARBOLINES; COLONIC DISEASES, FUNCTIONAL; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MIDDLE AGED; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME;

EID: 0035040899     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.5.596     Document Type: Note

References (4)

1. Non-colonic features of irritable bowel syndrome
2. Ranking of symptoms by patients with the irritable bowel syndrome
3. Design of treatment trials for functional gastrointestinal disorders
4. Clinical economics review: Irritable bowel syndrome